![]() |
市场调查报告书
商品编码
1828106
2025年角膜植入全球市场报告Corneal Implants Global Market Report 2025 |
近年来,角膜植入市场呈现强劲成长势头,市场规模从2024年的13.4亿美元增至2025年的14.2亿美元,复合年增长率为5.5%。预测期内的成长可归因于先进的手术技术、早期生物材料的创新、角膜移植的兴起、人们对眼科疾病认识的不断提高以及先锋外科医生的涌现。
预计未来几年角膜植入市场规模将强劲成长,2029年将达到18.7亿美元,复合年增长率为7.2%。预测期内的成长归因于个人化医疗方法的推进、可及性和认知度的提高、创新生物材料的开发、屈光矫正手术的增加以及人口老化。预测期内的主要趋势包括微创技术的兴起、监管支持和核准、认知度和可及性的提高、生物材料创新以及屈光矫正手术的增加。
角膜植入屈光矫正手术是一种外科介入手段,旨在透过植入人工或假体装置来替换或强化受损或患病的角膜。该手术旨在解决视力障碍并减轻相关疼痛。
角膜植入主要分为两类:人工角膜植入和人类角膜植入。人工角膜植入是专门设计用于替代受损或患病角膜的医疗设备。角膜植入采用多种技术製成,包括内皮角膜移植和穿透性角膜移植。这些手术用途广泛,包括治疗圆锥角膜、福克斯角膜营养不良、感染性角膜炎和角膜溃疡等疾病。角膜移植手术通常在医院或眼科中心等医疗机构进行。
2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响,尤其对影像处理设备、手术用不銹钢和一次性塑胶等进口零件产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战使情况更加复杂,因为由于关税而更换供应商通常需要医疗设备重新认证,导致市场进入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。
本研究报告是商业研究公司(The Business Research Company)新报告系列的一部分,该系列提供角膜植入市场统计数据,包括全球市场规模、区域份额、竞争对手的角膜植入市场份额、详细的角膜植入细分市场、市场趋势和商业机会,以及您在角膜植入行业取得成功所需的数据。本角膜植入市场研究报告对该行业的现状和未来趋势进行了详细分析,为您提供所需的一切观点。
未来五年7.2%的预测成长率,较我们先前对该市场的预测略有下降0.2%。下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自英国和英国等主要地区的生物相容性水凝胶材料和飞秒雷射切割系统征收关税直接影响美国,并可能导致视力恢復延迟和圆锥角膜治疗上升。此外,透过互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响,这种影响也将更为广泛地显现。
预计角膜疾病盛行率将在未来几年推动角膜植入市场的扩张。角膜疾病包括多种影响角膜(眼睛前部透明的圆顶状结构)的疾病,会导致视力障碍和不适。角膜疾病盛行率的不断上升推动了对角膜植入的需求,角膜植入物提供了多种解决方案,包括治疗角膜异常、改善角膜完整性、缓解症状和改善视力。例如,根据美国疾病管制中心 (CDC) 于 2022 年 12 月发布的数据,美国40 岁及以上人口中白内障(一种角膜疾病)的盛行率估计为 2,050 万,约占该年龄层人口的 17.2%。此外,预计到 2028 年这一数字将超过 3,000 万。因此,角膜疾病的快速增加是角膜植入市场成长的主要驱动力。
预计医疗保健支出的增加也将在短期内推动角膜植入市场的扩张。医疗保健支出是指在特定时期和地区内分配给医疗保健产品和服务的总资源(包括财政资源)。医疗保健投资的增加将推动眼科领域采用先进技术和手术技术,包括角膜植入的使用。例如,根据美国医疗保险和医疗补助服务中心于 2022 年 3 月发布的《2021-2030 年国家卫生支出 (NHE) 报告》,预计增长率表明,2021 年至 2030 年期间,国家医疗保健支出将以年均 5.1% 的速度增长,总额约为 6.8 兆美元。此外,预计 2021 年至 2030 年间,医疗保险支出将以每年 7.2% 的速度成长,医疗补助支出将以每年 5.6% 的速度成长。因此,医疗保健支出的增加是推动角膜植入市场成长的关键因素。
角膜植入市场的主要企业正致力于开发创新的角膜轮廓解决方案,以增强视力矫正和治疗各种角膜疾病。这些解决方案包括先进的手术技术和设备,旨在再形成角膜以改善视力并解决屈光不正和角膜疾病。例如,2024 年 6 月,专注于消除角膜失明的美国医疗设备开发商 CorneaGen 推出了角膜组织添加角膜移植术 (CTAK)。这种创新解决方案描述了一种针对角膜病眼的高效角膜轮廓修復方法。 CTAK 手术将供体角膜组织添加到现有角膜,而不是完全取代它。该方法旨在恢復角膜的自然轮廓,增强光学清晰度并改善患者的整体视觉效果。
角膜植入市场的主要企业正在建立策略伙伴关係关係,以推进和推出用于眼科应用的组织衍生植入。策略伙伴关係关係是指各公司利用彼此的优势和资源,实现互利共赢。例如,2022年7月,德国医疗技术公司卡尔蔡司医疗科技公司 (Carl Zeiss Meditec AG) 与美国再生医学公司 Precise Bio 合作,专注于开发和开发用于移植的人工角膜组织。该倡议专门针对需要内皮角膜移植和天然雀斑移植的患者,用于治疗圆锥角膜和视力矫正等疾病。此次伙伴关係充分利用了蔡司在眼科领域的全球领导地位以及 Precise 创新的 4D 生物製造平台技术。
2023年1月,美国製药保健公司Viatris Inc.分别以4.15亿美元和2.8亿美元收购了Oyster Point Pharma和Family Life Sciences。 Viatris Inc.旨在透过这些收购扩大其商业性影响力和产品组合,将自身定位为眼科护理领域的全球领导者,并满足眼科疾病患者和眼科护理专业人士尚未满足的需求。 Oyster Point Pharma是一家美国生物製药公司,专门从事眼科疾病新型治疗方法的识别、开发和商业化;而Family Life Sciences是一家印度药物开发平台,专注于眼科领域。
角膜植入市场的主要企业包括佛罗里达狮子眼库公司、爱尔康公司、Aurolab Aravind 眼科护理系统、CorneaGen、AJL Ophthalmic SA、DIOPTEX Co.Ltd.、KeraMed Inc.、阿拉巴马眼库公司、CorNeat Vision Ltd.、MediPhacos、EyeYon Science Ltd, Visiono LLC、麻萨诸塞州眼耳医院、Carl Zeiss Meditec AG、Precise Bio Inc、博士伦公司、强生视力、雅培医疗光学公司、STAAR Surgical Company、蔡司集团、豪雅公司、Rayner Intraocular Lenses Limited、HumanOptics AG、Morcher GmbH、Lenstec Inc、Ocular Systems Inc、Moria、Optics AG、Morcher GmbH、Lenstec Inc.、Ocular Inc、MoriaCI、Corcs AG、Clmt、Corphone Systems Inc.、Ocular
2024年,北美是角膜植入市场最大的地区。预计预测期内,亚太地区将成为全球角膜植入市场成长最快的地区。角膜植入市场报告涵盖亚太地区、西欧、东欧、北美、南美以及中东和非洲。
角膜植入市场报告涵盖的国家:澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙
角膜植入市场包括提供角膜移植服务的营业单位产生的收益,例如深层前板层角膜移植术 (DALK) 和无内皮细胞后弹力膜角膜移植术 (DWEK)。市场规模包括服务提供者销售或包含在其服务产品中的相关商品的价值。仅包括企业之间交易或销售给最终消费者的商品和服务。
Corneal implants involve a surgical intervention aimed at either replacing or enhancing a damaged or diseased cornea through the integration of an artificial or prosthetic device. This procedure is carried out to address visual impairments and alleviate associated pain.
The two primary categories of corneal implants are artificial corneal implants and human corneal implants. Artificial corneal implants are medical devices specifically designed to substitute a damaged or diseased cornea. Various techniques, such as endothelial keratoplasty and penetrating keratoplasty, are employed for corneal implants. These procedures serve diverse applications, including addressing conditions such as keratoconus, Fuchs dystrophy, infectious keratitis, corneal ulcers, among others. The implementation of corneal implant procedures typically takes place in medical facilities such as hospitals and ophthalmic centers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The corneal implants market research report is one of a series of new reports from The Business Research Company that provides corneal implants market statistics, including corneal implants industry global market size, regional shares, competitors with a corneal implants market share, detailed corneal implants market segments, market trends and opportunities, and any further data you may need to thrive in the corneal implants industry. This corneal implant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The corneal implants market size has grown strongly in recent years. It will grow from $1.34 billion in 2024 to $1.42 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to pioneering surgical techniques, early biomaterial innovation, emergence of keratoplasty, rising awareness of eye disorders, pioneering surgeons' contributions.
The corneal implants market size is expected to see strong growth in the next few years. It will grow to $1.87 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to personalized medicine approaches, greater accessibility and awareness, innovative biomaterials development, rise in refractive surgeries, growing aging population. Major trends in the forecast period include emergence of minimally invasive techniques, regulatory support and approvals, increased awareness and accessibility, innovation in biomaterials, rise in refractive surgery.
The forecast of 7.2% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on biocompatible hydrogel materials and femtosecond laser-cutting systems, sourced from key regions such as the UK and Mexico, which could lead to vision restoration delays and higher costs for keratoconus treatments.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated rise in the prevalence of corneal disorders is poised to drive the expansion of the corneal implant market in the coming years. Corneal disorders encompass a range of medical conditions affecting the cornea, the clear, dome-shaped front surface of the eye, leading to visual impairment and discomfort. The growing incidence of corneal disorders has resulted in an increased demand for corneal implants, offering diverse solutions for treating corneal abnormalities, enhancing corneal integrity, alleviating symptoms, and improving vision. As an example, data from the Center for Disease Control (CDC) in December 2022 revealed that in the United States, the prevalence of cataracts (a corneal disorder) among individuals aged over 40 is estimated at 20.5 million, constituting approximately 17.2% of the population in that age group. Moreover, this figure is projected to surpass 30 million by the year 2028. Consequently, the upsurge in corneal disorders is a key driver for the growth of the corneal implant market.
The escalating healthcare expenditure is also expected to propel the expansion of the corneal implants market in the foreseeable future. Healthcare expenditure denotes the total resources, including financial resources, allocated to healthcare goods and services within a specific period and geographical area. The increased investment in healthcare facilitates the adoption of advanced technologies and surgical techniques within the ophthalmology field, including the utilization of corneal implants. For instance, as per the 2021-2030 National Health Expenditure (NHE) report released by the Centers for Medicare & Medicaid Services in March 2022, the projected growth suggests an average annual increase of 5.1% in national health spending between 2021 and 2030, reaching a total of nearly $6.8 trillion. Furthermore, it is anticipated that from 2021 to 2030, Medicare spending will rise at a 7.2% annual pace, while Medicaid spending will increase at a 5.6% annual rate. Hence, the escalating healthcare expenditure is a significant factor propelling the growth of the corneal implants market.
Major companies in the corneal implants market are concentrating on developing innovative corneal contouring solutions to enhance vision correction and treat various corneal disorders. These solutions involve advanced surgical techniques and devices aimed at reshaping the cornea to improve vision and address refractive errors or corneal diseases. For instance, in June 2024, CorneaGen, a US-based developer of medical devices focused on eliminating corneal blindness, launched the Corneal Tissue Addition for Keratoplasty (CTAK). This innovative solution offers a highly effective approach to corneal contouring for keratoconic eyes. The CTAK technique involves adding donor corneal tissue to the existing cornea instead of completely replacing it. This method aims to restore the natural contour of the cornea, thereby enhancing optical clarity and improving overall visual outcomes for patients.
Major players in the corneal implants market are embracing strategic partnerships to advance and introduce tissue-derived implants for ophthalmological applications. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefit and success. For instance, in July 2022, Carl Zeiss Meditec AG, a German medical technology company, collaborated with Precise Bio, a US regenerative medicine company, focusing on the development and market launch of engineered corneal tissue for transplants. This initiative specifically caters to patients in need of endothelial keratoplasty and natural lenticule transplants for conditions such as keratoconus and vision correction. The partnership leverages ZEISS' global leadership in ophthalmology and Precise's innovative 4D bio-fabrication platform technology.
In January 2023, Viatris Inc., a US-based pharmaceutical and healthcare corporation, completed the acquisitions of Oyster Point Pharma and Family Life Sciences for $415 million and $280 million, respectively. Through these acquisitions, Viatris Inc. aims to expand its commercial presence and portfolio, positioning itself as a global leader in eye care, and addressing the unmet needs of patients with ophthalmic diseases and eye care professionals. Oyster Point Pharma, a US biopharmaceutical company, specializes in identifying, developing, and marketing novel treatments for eye diseases, while Family Life Sciences, an Indian drug development platform, specializes in ophthalmology.
Major companies operating in the corneal implants market include Florida Lions Eye Bank Inc., Alcon Inc., Aurolab Aravind Eye Care System, CorneaGen, AJL Ophthalmic SA, DIOPTEX Co. Ltd., KeraMed Inc., Alabama Eye Bank Inc., CorNeat Vision Ltd., MediPhacos, EyeYon Medical Ltd., Linkocare Life Sciences AB, Price Vision Group, Cornea Biosciences LLC, Massachusetts Eye and Ear Infirmary, Carl Zeiss Meditec AG, Precise Bio Inc., Bausch & Lomb Incorporated, Johnson & Johnson Vision, Abbott Medical Optics Inc., STAAR Surgical Company, ZEISS Group, Hoya Corporation, Rayner Intraocular Lenses Limited, HumanOptics AG, Morcher GmbH, Lenstec Inc., Ocular Systems Inc., Moria SA, DORC International BV, Coroneo Pty Ltd, FCI Ophthalmics Inc.
North America was the largest region in the cornea implants market in 2024. Asia Pacific is expected to be the fastest-growing region in the global cornea implants market during the forecast period. The regions covered in the corneal implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the corneal implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The corneal implants market includes revenues earned by entities by providing corneal implantation services, including deep anterior lamellar keratoplasty (DALK) and Descemet rhexis without endothelial keratoplasty (DWEK). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Corneal Implants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on corneal implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for corneal implants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The corneal implants market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.